[go: up one dir, main page]

BRPI0907789A2 - derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos - Google Patents

derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos

Info

Publication number
BRPI0907789A2
BRPI0907789A2 BRPI0907789A BRPI0907789A BRPI0907789A2 BR PI0907789 A2 BRPI0907789 A2 BR PI0907789A2 BR PI0907789 A BRPI0907789 A BR PI0907789A BR PI0907789 A BRPI0907789 A BR PI0907789A BR PI0907789 A2 BRPI0907789 A2 BR PI0907789A2
Authority
BR
Brazil
Prior art keywords
alpha
glucocorticosteroids
derivatives
therapy
report
Prior art date
Application number
BRPI0907789A
Other languages
English (en)
Inventor
Burkamp Frank
Bladh Häkan
Lepistö Matti
Anderson Paul
Bhattacharyya Sumita
Ivanova Svetlana
Mussie Tesfaledet
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0907789A2 publication Critical patent/BRPI0907789A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

derivados 16-alfa e 17-alfa de glicocorticosteroides e seus usos a presente invenção provê compostos da fórmula(l) em que r1 r2 r3 r4 r5 e r6 são conforme definidos no relatório, um processo para o seu preparo, composições farmacêuticas contendo-os e o seu uso em terapia.
BRPI0907789A 2008-02-27 2009-02-27 derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos BRPI0907789A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3180108P 2008-02-27 2008-02-27
PCT/SE2009/050220 WO2009108118A1 (en) 2008-02-27 2009-02-27 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use

Publications (1)

Publication Number Publication Date
BRPI0907789A2 true BRPI0907789A2 (pt) 2019-01-22

Family

ID=41016344

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907789A BRPI0907789A2 (pt) 2008-02-27 2009-02-27 derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos

Country Status (11)

Country Link
US (1) US20110294766A1 (pt)
EP (1) EP2257568A1 (pt)
JP (1) JP2011513303A (pt)
KR (1) KR20110005236A (pt)
CN (1) CN102015750A (pt)
AU (1) AU2009217824A1 (pt)
BR (1) BRPI0907789A2 (pt)
CA (1) CA2716476A1 (pt)
MX (1) MX2010009022A (pt)
RU (1) RU2010133722A (pt)
WO (1) WO2009108118A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009044200A1 (en) 2007-10-04 2009-04-09 Astrazeneca Ab Steroidal [3, 2-c] pyrazole compounds, with glucocorticoid activity
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UA108858C2 (xx) 2009-09-11 2015-06-25 Похідні ізоксалідину
US8470812B2 (en) 2009-12-30 2013-06-25 Arqule, Inc. Substituted benzo-pyrimido-tetrazolo-diazepine compounds
AR085817A1 (es) * 2011-03-15 2013-10-30 Chiesi Farma Spa Derivados de isoxazolidina
US9155747B2 (en) * 2012-09-13 2015-10-13 Chiesi Farmaceutici S.P.A. Isoxazolidine derivatives
PE20190622A1 (es) * 2016-06-02 2019-04-26 Abbvie Inc Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
HUE054428T2 (hu) 2017-12-01 2021-09-28 Abbvie Inc Glükokortikoid receptor agonista és annak immunkonjugátumai
CN109575095A (zh) * 2019-01-20 2019-04-05 湖南科瑞生物制药股份有限公司 一种16a-羟基醋酸泼尼松龙的制备方法
CN112851743A (zh) * 2019-11-27 2021-05-28 重庆华邦胜凯制药有限公司 一种氧化杂质的制备方法
EP4289857A4 (en) * 2021-02-04 2025-05-07 Shanghai Senhui Medicine Co., Ltd. Drug conjugate of glucocorticoid receptor agonist, and application thereof in medicine
TWI899455B (zh) 2021-03-23 2025-10-01 美商美國禮來大藥廠 糖皮質素受體激動劑
AR125084A1 (es) * 2021-03-23 2023-06-07 Lilly Co Eli Agonistas del receptor de glucocorticoides novedosos
AR125079A1 (es) 2021-03-23 2023-06-07 Lilly Co Eli Agonistas de receptores de glucocorticoides sustituidos con carboxi
WO2023040793A1 (zh) * 2021-09-14 2023-03-23 映恩生物制药（苏州）有限公司 一种抗炎症的化合物及其用途
AU2023341157A1 (en) * 2022-09-15 2025-04-24 Adcentrx Therapeutics Inc. Novel glucocorticoid receptor agonists and immunoconjugates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
SE8306370D0 (sv) * 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
WO1994025478A1 (en) * 1993-04-29 1994-11-10 Instytut Farmaceutyczny 16α,17α-ACETAL GLUCOCORTICOSTEROIDAL DERIVATIVES
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
WO2007054974A2 (en) * 2005-09-28 2007-05-18 Arch Pharmalab Limited A green chemistry process for the preparation of pregnadiene esters

Also Published As

Publication number Publication date
RU2010133722A (ru) 2012-04-10
WO2009108118A1 (en) 2009-09-03
AU2009217824A1 (en) 2009-09-03
US20110294766A1 (en) 2011-12-01
KR20110005236A (ko) 2011-01-17
JP2011513303A (ja) 2011-04-28
WO2009108118A9 (en) 2010-09-02
MX2010009022A (es) 2010-09-07
EP2257568A1 (en) 2010-12-08
CA2716476A1 (en) 2009-09-03
CN102015750A (zh) 2011-04-13

Similar Documents

Publication Publication Date Title
BRPI0907789A2 (pt) derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos
BRPI0915064B8 (pt) derivados de quinoxalinadiona, seus usos, e medicamentos
BRPI0821004A8 (pt) Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
UY30759A1 (es) Compuestos quimicos
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
BR112015026023A2 (pt) derivados de 2- aminopirido[4,3-d]pirimidin-5-ona e seu uso como inibidores de wee-1
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
BR112015014372A8 (pt) inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas".
AR047928A1 (es) Derivados de tetrahidropiridoindol
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
DOP2010000259A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
ECSP11011439A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
ECSP088288A (es) DERIVADOS DE 7-(2-AMINO-1-HIDROXI-ETIL)-4-HIDROXIBENZOTIAZOL-2(3H)-ONA COMO AGONISTAS DE LOS ADRENOCEPTORES ß2
BR112015020772A2 (pt) compostos de pirimidina e piridina e seu uso
BR112016011170A8 (pt) derivados de heteroaril ácido butanoico, seus usos, combinação e composição farmacêutica
BR112013000254A2 (pt) derivados heterocíclicos 1-fenil-substituídos e seu uso como moduladores do receptor de prostaglandina d2
CR9469A (es) Derivados de urea, metodos para su fabricacion y usos para los mismos
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BR112022001330A2 (pt) Derivados de 3,6-diamino-piridazin-3-ila, composições farmacêuticas contendo-os e seus usos como agentes pró-apoptóticos

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A, 8A, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2508 DE 29-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]